Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics
GET POWR RATINGS... FREE!
AVDL Stock Price Chart Interactive Chart >
AVDL Price/Volume Stats
|Current price||$2.57||52-week high||$11.59|
|Prev. close||$2.44||52-week low||$1.05|
|Day high||$2.57||Avg. volume||2,191,342|
|50-day MA||$3.39||Dividend yield||N/A|
|200-day MA||$6.83||Market Cap||151.73M|
Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio
Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.
Most Popular Stories View All
AVDL Latest News Stream
|Loading, please wait...|
AVDL Latest Social Stream
View Full AVDL Social Stream
Latest AVDL News From Around the Web
Below are the latest news stories about Avadel Pharmaceuticals Plc that investors may wish to consider to help them evaluate AVDL as an investment opportunity.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced the appointment of Douglas Williamson, MBChB, as Chief Medical Officer. “Doug is an outstanding addition to the Avadel leadership team given his extensive experience in the biopharmaceutical industry leading R&D, clinical development and medical affairs teams in the neuroscience field,” said Greg Divis, Chief Executive Offic
DUBLIN, Ireland, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 1:40 p.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investo
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Selecta Biosciences (SELB)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) and Selecta Biosciences (SELB – Research Report) with bullish sentiments. Avadel Pharmaceuticals (AVDL) Needham analyst Ami Fadia maintained a Buy rating on Avadel Pharmaceuticals today and set a price target of $15.00. The company's shares closed last Monday at $6.92, close to its 52-week low of $6.29. According to TipRanks.
A Bull Market Continues To Unfold On Avadel Pharmaceuticals plc (NASDAQ: AVDL), As It Continued To Rise 12.57% In Year-To-Date
During the last session, Avadel Pharmaceuticals plc (NASDAQ:AVDL)s traded shares were 0.66 million, with the beta value of the company hitting 1.11. At the end of the trading day, the stocks price was $7.52, reflecting an intraday loss of -3.47% or -$0.27. The 52-week high for the AVDL share is $11.59, that puts it down A Bull Market Continues To Unfold On Avadel Pharmaceuticals plc (NASDAQ: AVDL), As It Continued To Rise 12.57% In Year-To-Date Read More »
AVDL Price Returns
Continue Researching AVDLWant to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:
Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch